ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Mometason Viatris 50 μg, Dosier-Nasenspray - 
68335001 Mylan Pharma GmbH
Mometason Viatris 50 μg, Dosier-Nasenspray09.02.2022
  09.02.2022
Mometasone (R01AD09) 
WHO-DDD08.02.2027
 
12.02.30. 
B  
No 
  
PR  
k.A.PR
  
7680683350017Synthetika
  
Composition
mometasoni-17 furoas 0.5 mg ut mometasoni-17 furoas monohydricus, benzalkonii chloridum 0.20 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata q.s. ad solutionem pro 1 g corresp. mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140.
Packungsbestandteile
Nasal spray
 
 
Active AgentDose
Mometasone 17 Furoate0.5 mg/g
 
Inactive agentsDose
Citric Acid Monohydrate 
Aqua Purificata 
Benzalkonium Chloride0.2 mg/g
Carmellose Sodium 
Cellulosum Microcristallinum 
Glycerol 
Natrii Citras Anhydricus 
Polysorbatum 80 
Source
Data was imported : 08.03.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home